OPCH:NSD-Option Care Health Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 23.55

Change

-6.95 (-22.79)%

Market Cap

USD 5.14B

Volume

8.47M

Analyst Target

USD 19.80
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.90 (-0.57%)

USD 8.50B
ACHC Acadia Healthcare Company Inc

+0.48 (+0.93%)

USD 4.84B
SGRY Surgery Partners Inc

-0.65 (-2.16%)

USD 4.02B
AMED Amedisys Inc

-0.08 (-0.08%)

USD 3.12B
LFST Lifestance Health Group Inc

-0.01 (-0.15%)

USD 2.67B
ASTH Astrana Health Inc

-0.23 (-0.41%)

USD 2.55B
ADUS Addus HomeCare Corporation

-4.09 (-3.15%)

USD 2.35B
AVAH Aveanna Healthcare Holdings In..

+0.01 (+0.20%)

USD 0.96B
HCSG Healthcare Services Group Inc

+0.03 (+0.27%)

USD 0.76B
CMPS Compass Pathways Plc

-0.03 (-0.48%)

USD 0.44B

ETFs Containing OPCH

W311:XETRA HAN-GINS Indxx Healthcare.. 4.54 % 0.00 %

-0.06 (-0.21%)

USD 0.02B
W311:F HAN-GINS Indxx Healthcare.. 4.54 % 0.00 %

-0.08 (-0.21%)

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 4.54 % 0.00 %

-0.09 (-0.21%)

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 4.54 % 0.00 %

-0.01 (-0.21%)

N/A
MEDI Harbor Health Care ETF 4.33 % 0.00 %

-0.38 (-0.21%)

USD 0.02B
VCAV:XETRA VanEck Smart Home Active .. 3.24 % 0.00 %

N/A

USD 0.01B
CAVE:LSE VanEck Smart Home Active .. 3.09 % 0.00 %

N/A

N/A
CVGB:LSE VanEck Smart Home Active .. 2.95 % 0.00 %

N/A

USD 2.24M
CAVE:SW VanEck Smart Home Active .. 2.86 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -30.10% 44% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.10% 44% F 25% F
Trailing 12 Months  
Capital Gain -17.86% 48% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.86% 48% F 27% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 26.34% 70% C- 79% B-
Dividend Return 26.34% 70% C- 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 33.76% 67% D+ 56% F
Risk Adjusted Return 78.03% 96% N/A 91% A-
Market Capitalization 5.14B 96% N/A 89% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.